- Home
- NRXP vs INTT Comparison
NRXP vs INTT Comparison
Compare NRXP & INTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NRXP | INTT |
|---|---|---|
| Founded | 2015 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 153.2M | 176.5M |
| IPO Year | 2017 | 1997 |
Fundamental Metrics
Financial Performance| Metric | NRXP | INTT |
|---|---|---|
| Price | $3.24 | $13.96 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | ★ $38.25 | $13.50 |
| AVG Volume (30 Days) | ★ 1.1M | 147.0K |
| Earning Date | 05-14-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 69.70 | N/A |
| EPS | N/A | ★ 0.06 |
| Revenue | $1,225,000.00 | ★ $66,801,000.00 |
| Revenue This Year | $2,547.84 | $15.82 |
| Revenue Next Year | $1,591.73 | $9.10 |
| P/E Ratio | ★ N/A | $226.50 |
| Revenue Growth | N/A | ★ 66.06 |
| 52 Week Low | $1.65 | $6.63 |
| 52 Week High | $5.06 | $20.00 |
Technical Indicators
Market Signals| Indicator | NRXP | INTT |
|---|---|---|
| Relative Strength Index (RSI) | 40.93 | 47.54 |
| Support Level | $2.88 | $12.75 |
| Resistance Level | $3.33 | $15.34 |
| Average True Range (ATR) | 0.32 | 1.00 |
| MACD | -0.00 | 0.16 |
| Stochastic Oscillator | 30.83 | 73.09 |
Price Performance
Historical ComparisonAbout NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
About INTT inTest Corporation
inTest Corp is a supplier of test and process technology solutions for use in manufacturing and testing across a wide range of markets, including Semi, Auto/EV, Defense/Aerospace, Industrial, Life Sciences, Safety/Security, and Other. The Company has three operating segments, which are also its reportable segments and reporting units: Electronic Test, which generates the majority of its revenue and includes semiconductor test equipment, flying probe, and in-circuit testers; Environmental Technologies, which includes thermal test, process, and storage products; and Process Technologies, which includes induction heating and video imaging products. The Company generates the maximum revenue from the U.S.